Medical Devices Startups

Segmed provides structured, de-identified medical imaging data and multimodal datasets from diverse populations to support research in AI and healthcare. The platform enables researchers and pharmaceutical companies to access fit-for-purpose imaging studies for diagnostics, therapeutics, and algorithm development.

9 investors

ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease. It is a privately held company operating in the medical device and healthcare industry.

9 investors

Siphox Health develops early diagnostic testing technology to detect and manage chronic diseases at home, delivered as a painless 5-minute test that enables frequent monitoring. The company targets the U.S. healthcare system to reduce the health and economic burden of chronic disease.

9 investors

Slope provides software to manage the biospecimen lifecycle in clinical trials, giving research sites, sponsors, CROs, and labs oversight of clinical sample inventory and real-time data. It serves the clinical research industry with a site-first platform connecting a network of NCI sites and academic medical centers.

9 investors

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases. The company uses proprietary platform technologies to create targeted and durable Treg cell therapies.

9 investors

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline. The company serves patients with motor impairment and cognitive decline using a minimally invasive approach inspired by cardiac interventional procedures.

9 investors

Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.

9 investors

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

9 investors

Vistapath develops technology solutions to modernize pathology lab operations, helping pathology laboratories improve quality, efficiency, and consistency in critical lab processes.

9 investors

Wearlinq develops the eWave, a wireless, FDA-cleared 6-lead continuous ECG cardiac monitor with a patient smartphone app and the LiveLinq platform for clinicians to review ECG waveforms and reports. Its products serve cardiologists and clinical teams for continuous cardiac monitoring and diagnostic reporting.

9 investors

Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.

9 investors

Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.

8 investors

Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors. The company serves oncology patients and healthcare providers in the cancer care sector.

8 investors

Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling. It serves pharmaceutical and life-science researchers as an alternative to animal studies and Caco-2 cell lines, offering ready-to-use kits and custom studies.

8 investors

Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease. It serves healthcare providers and pharmaceutical companies for cognitive diagnostics, clinical trial enrichment, and disease progression research in the neurological care field.

8 investors

Aluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases. The device gathers daily health data and transmits it in real time to parents and healthcare providers.

8 investors

Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers. The company focuses on advancing DDR-based therapies through strategic partnerships.

8 investors

Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease. The company is a clinical-stage biotechnology firm focused on personalized neuron replacement therapies.

8 investors

Atomic Alchemy developed technology and facilities for producing radioisotopes for medical, industrial, and research applications, planning dedicated isotope-production reactors in Idaho. Acquired by Oklo in 2024.

8 investors

Béa provides at-home fertility treatments that bridge the gap between natural conception attempts and in-vitro fertilization, offering clinic-level care with personalized support. The company serves couples and individuals seeking early-stage fertility care accessible outside traditional clinical settings.

8 investors

Beacon Biosignals develops AI-powered EEG analytics technology to improve diagnosis and treatment of neurological, psychiatric, and sleep disorders. The company combines machine learning with neuroscience domain expertise to accelerate innovation for biopharma partners and clinical research organizations.

8 investors

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases. The company works across multiple therapeutic areas to advance precision medicine treatments at the molecular level.

8 investors

Osteoboost is an FDA-cleared bone health solution designed for postmenopausal women with osteopenia. The company was founded by physicians, engineers, and entrepreneurs to address low bone mass and osteoporosis prevention through clinical innovation.

8 investors

Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor. The company serves patients with chronic neurological and related conditions using bioelectronic medicine technology.

8 investors